J Transcat Intervent.2023;31:eA20230013.
Percutaneous edge-to-edge mitral regurgitation valve repair after transcatheter aortic valve implantation
Júlio Cesar Schulz
, Felipe Barbosa Amaral
, Paloma Farina de Lima
, Marcelo Vitola Dreckmann
, Edson Tafner
, Giulliano Gardenghi
DOI: 10.31160/JOTCI202331A20230013
ABSTRACT
Moderate to severe mitral regurgitation is observed in 17 to 35% of patients undergoing transcatheter aortic valve implantation. A study reporting mitral regurgitation after transcatheter aortic valve implantation due to aortic stenosis demontrated 50% of patients with moderate to severe reflux showed improvement in regurgitation, and 8.7% showed worsening of the condition, which led to increased mortality. This progression suggested conventional management, based on medication optimization, may not be able to prevent poor outcomes. We report a case on the clinical course of a patient with mitral regurgitation after transcatheter aortic valve implantation, and the use of MitraClip® as an alternative treatment and its benefits.
222
